Volker Karl
Non-Profit & Charitable Organizations · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
GermanyWebsite
www.krebs-kompass.deRevenue
<$5 MillionIndustry
About Volker Karl
Is Volker Karl your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Volker Karl is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Volker Karl recently announced quarterly report
Product Launch: Get notified when Volker Karl launches new products
Funding: Get notified immidiatlly once Volker Karl has new funding data
Click to see if Volker Karl had a recent Job posting/layoffs
Check if Volker Karl has recently received funding, and reach out quickly before it becomes old news!
Volker Karl, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Volker Karl
Recommended Actions
Reach out to Masked Content who joined Volker Karl as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Volker Karl is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Volker Karl is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Volker Karl.
Volker Karl Tech Stack
A closer look at the technologies used by Volker Karl
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Volker Karl
Krebs-Kompass is a non-profit organization that operates the oldest German-speaking forum for cancer patients and their relatives, established in 1997. The forum provides a platform for sharing information and experiences related to various types of cancer, treatment options, and support for affected individuals. It is designed for cancer patients,... Read More